Emerging Infectious Diseases, a CDC journal, is retracting a 2010 paper about swine flu by a group of Minnesota researchers who acknowledged misinterpreting their results.
The study, a letter titled “Triple Reassortant Swine Influenza A (H3N2) Virus in Waterfowl,” claimed to shed new light on how flu viruses might jump between species: Continue reading Paper on how swine flu might spread to birds retracted for error
A group of smoking researchers — no, not scientists who are on fire; scientists who study the effects of tobacco smoke — has retracted a 2009 article after deciding that they were no longer “satisfied with the quality of the data.”
The paper, “Cigarette Smoke–induced Oxidative/Nitrosative Stress Impairs VEGF- and Fluid Shear Stress–Mediated Signaling in Endothelial Cells,” came from the lab of Irfan Rahman, a lung disease expert at the University of Rochester. It appeared online in 2009 in Antioxidants & Redox Signaling, which will be familiar to readers watching the case of Dipak Das.
As the notice explains: Continue reading Scientists retract paper because they’re “not satisfied with the quality of some of the data”
The journal Environmental Entomology (that’s insects, not words) is retracting a 2010 paper on a sugarcane-loving borer insect by a group from south Florida.
The article, “Life Table Studies of Elasmopalpus lignosellus (Lepidoptera: Pyralidae) on Sugarcane,” came from the Everglades Research & Education Center, an arm of the University of Florida.
According to the notice: Continue reading Sweet nothings: Buggy data force retraction of sugarcane pest paper
An accounting professor at a Boston-area college has resigned a month after publishing a retraction that has sparked extensive discussion on Retraction Watch.
The Boston Globe reported late last week that James E. Hunton will leave Bentley University on December 31, with a spokesperson telling the paper he was leaving for “family and health reasons.”
Hunton and a co-author retracted “A Field Experiment Comparing the Outcomes of Three Fraud Brainstorming Procedures: Nominal Group, Round Robin, and Open Discussion” from the Accounting Review on November 9. The notice was scant, but the authors left a comment on our post with details: Continue reading Accounting professor resigns following retraction
Terry S. Elton, a researcher at Ohio State University in Columbus who studies genetic expression in various heart conditions and Down syndrome, has been sanctioned by the U.S. Office of Research Integrity for fabricating and/or falsifying data in a number of NIH grants and resulting papers.
According to an OSU statement sent to Retraction Watch last night, it was an anonymous whistleblower who alerted the university to the potential misconduct in July 2010. The ORI report notes that he two OSU investigations, along with the ORI investigation, found that Elton: Continue reading ORI: Ohio State researcher manipulated two dozen figures in NIH grants, papers
The U.S. Office of Research Integrity is investigating work done at a Caltech lab after researchers there couldn’t replicate it, and retracted a paper based on the findings.
Here’s the notice, which ran this week in the Proceedings of the National Academy of Sciences (PNAS): Continue reading ORI investigating work from Caltech lab as PNAS paper is retracted
The Journal of Neuroscience has retracted a 2011 paper by an international group of scientists, including the prominent Maryland researcher Ronald Dubner, but readers won’t know why.
As the notice “explains“: Continue reading Journal of Neuroscience retraction, typically opaque, from author with history of errors
Last month, we brought you news that Pfizer had retracted a paper in the Journal of Clinical Oncology
purporting to show a benefit of their experimental drug for lung cancer figitumumab after discovering that its clinical lead on the project had done analyses improperly.
There’s been another retraction, of a related paper, in the British Journal of Cancer, “Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.” Here’s the notice: Continue reading Another retraction for Pfizer’s experimental cancer treatment figitumumab
In October, we noted the apparent record holder for longest time between publication and retraction: 25 years, for “Retention of the 4-pro-R hydrogen atom of mevalonate at C-2,2′ of bacterioruberin in Halobacterium halobium,” published in the Biochemical Journal in 1980 and retracted in 2005. (Although an author requested that another 52-year-old paper be retracted, it remains untouched in the literature.)
That record has now been broken. Congratulations to the Journal of Steroid Biochemistry and Molecular Biology and the authors of a December 1985 paper, “Increasing the response rate to cytotoxic chemotherapy by endocrine means.” Here’s the notice, which appears in the January 2013 issue of the journal, making 27 years — and a month, if you’re counting: Continue reading A new record: A retraction, 27 years later
Dipak Das, the resveratrol researcher found guilty of more than 100 counts of misconduct by the University of Connecticut, has two more retractions for his resume. But that’s not the most interesting part of this post, so keep reading after the notices.
Both retractions appeared in the October 2012 issue of the Journal of Cellular and Molecular Medicine. Here’s the first notice: Continue reading Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss